Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Deferred Taxes: 2011-2022

Historic Deferred Taxes for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2022 value amounting to -$26.0 million.

  • Avadel Pharmaceuticals' Deferred Taxes fell 292.46% to -$51.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$26.0 million, marking a year-over-year decrease of 266.12%. This contributed to the annual value of -$26.0 million for FY2022, which is 266.12% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Deferred Taxes stood at -$26.0 million for FY2022, which was down 266.12% from $15.7 million recorded in FY2021.
  • Avadel Pharmaceuticals' 5-year Deferred Taxes high stood at $19.2 million for FY2018, and its period low was -$26.0 million during FY2022.
  • In the last 3 years, Avadel Pharmaceuticals' Deferred Taxes had a median value of $7.4 million in 2020 and averaged -$976,000.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Deferred Taxes soared by 638.58% in 2018 and then tumbled by 266.12% in 2022.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Deferred Taxes stood at $19.2 million in 2018, then slumped by 66.93% to $6.3 million in 2019, then climbed by 17.32% to $7.4 million in 2020, then skyrocketed by 110.82% to $15.7 million in 2021, then slumped by 266.12% to -$26.0 million in 2022.